ExodusPoint Capital Management’s AnaptysBio ANAB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$403K	Sell	7,260 -76,053	-91%	-$4.09M	﹤0.01%	1247
2025 Q4	$4.04M	Buy	83,313 +56,813	+214%	+$2.21M	0.04%	556
2025 Q3	$811K	Buy	26,500 +2,744	+12%	+$63K	0.01%	1031
2025 Q2	$527K	Buy	23,756 +1,812	+8%	+$37.9K	0.01%	1138
2025 Q1	$408K	Buy	+21,944	New	+$366K	0.01%	1157
2024 Q4	–	Sell	-12,284	Closed	-$412K	–	1488
2024 Q3	$412K	Sell	12,284 -128,215	-91%	-$4.38M	﹤0.01%	1260
2024 Q2	$3.52M	Buy	+140,499	New	+$3.27M	0.04%	562
2024 Q1	–	Sell	-24,672	Closed	-$528K	–	1467
2023 Q4	$528K	Sell	24,672 -15,867	-39%	-$274K	0.01%	1020
2023 Q3	$728K	Sell	40,539 -48,046	-54%	-$917K	0.01%	1091
2023 Q2	$1.8M	Sell	88,585 -45,457	-34%	-$922K	0.02%	854
2023 Q1	$2.92M	Buy	134,042 +38,784	+41%	+$943K	0.03%	733
2022 Q4	$2.95M	Buy	95,258 +59,017	+163%	+$1.67M	0.05%	506
2022 Q3	$925K	Sell	36,241 -71,383	-66%	-$1.67M	0.01%	1141
2022 Q2	$2.19M	Buy	107,624 +30,178	+39%	+$668K	0.03%	743
2022 Q1	$1.92M	Buy	+77,446	New	+$2.34M	0.03%	801
2021 Q4	–	Sell	-7,599	Closed	-$206K	–	2136
2021 Q3	$206K	Sell	7,599 -26,080	-77%	-$662K	﹤0.01%	1768
2021 Q2	$873K	Buy	+33,679	New	+$807K	0.01%	1072
2020 Q4	–	Sell	-13,949	Closed	-$206K	–	1930
2020 Q3	$206K	Sell	13,949 -14,951	-52%	-$270K	0.01%	1462
2020 Q2	$646K	Buy	+28,900	New	+$528K	0.02%	951